Biomarkers of cardiac hypertrophy, such as Anp, Bnp, and Myh7, were also significantly increased in the siTEAD1 group compared to those in the siControl group (Figure 2H–J). The gene discussed is NPPB; the disease is cardiac hypertrophy.